D-Luciferin potassium salt, chemiluminescent luciferase substrate (ab143655)
Key features and details
- Chemiluminescent luciferase substrate
- CAS Number: 115144-35-9
- Purity: >= 95%
Soluble in water to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
D-Luciferin potassium salt, chemiluminescent luciferase substrate -
Description
Chemiluminescent luciferase substrate -
Biological description
-
Purity
>= 95% -
General notes
This product is manufactured by BioVision, an Abcam company and was previously called 7903 Luciferin, Potassium Salt. 7903-100 is the same size as the 100 mg size of ab143655.
-
CAS Number
115144-35-9 -
Chemical structure
Properties
-
Chemical name
(2Z,4S)-2-(6-Oxo-1,3-benzothiazol-2-ylidene)-1,3-thiazolidine-4-carboxylate potassium salt
-
Molecular weight
318.42 -
PubChem identifier
135478035 -
Storage instructions
Store at -20°C. It is important to note that this product is reported to be light sensitive. Store In the Dark. Store under desiccating conditions. -
Solubility overview
Soluble in water to 100 mM
-
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
C1[C@@H](N=C(S1)C2=NC3=C(S2)C=C(C=C3)O)C(=O)[O-].[K+] -
Source
Synthetic
-
Research areas
Images
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (6)
ab143655 has been referenced in 6 publications.
- Wang C et al. Dendritic cells direct circadian anti-tumour immune responses. Nature 614:136-143 (2023). PubMed: 36470303
- Perera LA et al. Infancy-onset diabetes caused by de-regulated AMPylation of the human endoplasmic reticulum chaperone BiP. EMBO Mol Med 15:e16491 (2023). PubMed: 36704923
- Stepanenko AA et al. Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures. Mol Ther Oncolytics 24:230-248 (2022). PubMed: 35071746
- Zhang M et al. ITPR3 facilitates tumor growth, metastasis and stemness by inducing the NF-?B/CD44 pathway in urinary bladder carcinoma. J Exp Clin Cancer Res 40:65 (2021). PubMed: 33573671
- Horiuchi K et al. Thawed cryopreserved synovial mesenchymal stem cells show comparable effects to cultured cells in the inhibition of osteoarthritis progression in rats. Sci Rep 11:9683 (2021). PubMed: 33958682
- Lai Y et al. STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling. Front Cell Dev Biol 9:621147 (2021). PubMed: 34295886